Episode 1774 • • 1:35:03 - 1:39:21
1774: Leave it to Bibi
Lenacapavir Approval, Breakthrough HIV Prevention Injection
The FDA has approved Lenacapavir, a twice-yearly injection that is reportedly over 99.9% effective at preventing HIV. Manufacturer Gilead Sciences set the list price at approximately $28,000 per year. While medical professionals hail it as a breakthrough for those who struggle with daily pill compliance, critics question the high cost and the reliance on federal funding for access.